ImmuneXcite Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

ImmuneXcite General Information

Description

Developer of next generation immune-activating anti-tumor biotherapeutics designed to leverage both the innate and adaptive immune responses to selectively treat a wide range of tumor type. The company's immune-activating anti-tumor biotherapeutics use novel immunotherapy platform that is focused on developing monoclonal antibodies which identifies a fungal carbohydrate responsible for stimulating the innate immune system, enabling health care providers to limit tumor growth and metastasis in patient's body.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 266 2nd Avenue
  • Suite C
  • Waltham, MA 02451
  • United States
+1 (781)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • 266 2nd Avenue
  • Suite C
  • Waltham, MA 02451
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuneXcite Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 12-Oct-2017 Completed Out of Business
6. Early Stage VC 01-Feb-2017 Completed Generating Revenue
5. Later Stage VC (Series A1) 30-Mar-2016 Completed Generating Revenue
4. Later Stage VC (Series B) 20-Dec-2013 Completed Generating Revenue
3. Grant 04-Sep-2013 Completed Generating Revenue
2. Debt - General 19-Dec-2012 $984K $3.4M Completed Startup
1. Seed Round 03-Jan-2012 $2.42M $2.42M Completed Startup
To view ImmuneXcite’s complete valuation and funding history, request access »

ImmuneXcite Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
To view ImmuneXcite’s complete cap table history, request access »

ImmuneXcite Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of next generation immune-activating anti-tumor biotherapeutics designed to leverage both the innate and adapt
Biotechnology
Waltham, MA

Zurich, Switzerland
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmuneXcite Competitors (92)

One of ImmuneXcite’s 92 competitors is Araris, a Formerly VC-backed company based in Zurich, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Araris Formerly VC-backed Zurich, Switzerland
Biocon Biologics Formerly PE-Backed Bengaluru, India
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Apellis Pharmaceuticals Formerly VC-backed Waltham, MA
Alaunos Therapeutics Formerly VC-backed Fort Lauderdale, FL
You’re viewing 5 of 92 competitors. Get the full list »

ImmuneXcite Patents

ImmuneXcite Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3582810-A1 ß-1,6-glucan therapeutic antibody conjugates Pending 07-Dec-2016
EP-3582810-A4 ß-1,6-glucan therapeutic antibody conjugates Pending 07-Dec-2016
US-11865135-B2 ß-1,6-glucan therapeutic antibody conjugates Active 07-Dec-2016
US-20200030360-A1 ß-1,6-glucan therapeutic antibody conjugates Active 07-Dec-2016
EP-3551685-A1 ß-1,6-glucan trastuzumab antibody conjugates Inactive 07-Dec-2016 A61P35/00
To view ImmuneXcite’s complete patent history, request access »

ImmuneXcite FAQs

  • When was ImmuneXcite founded?

    ImmuneXcite was founded in 2007.

  • Where is ImmuneXcite headquartered?

    ImmuneXcite is headquartered in Waltham, MA.

  • What industry is ImmuneXcite in?

    ImmuneXcite’s primary industry is Biotechnology.

  • Is ImmuneXcite a private or public company?

    ImmuneXcite is a Private company.

  • What is ImmuneXcite’s current revenue?

    The current revenue for ImmuneXcite is .

  • How much funding has ImmuneXcite raised over time?

    ImmuneXcite has raised $19.3M.

  • Who are ImmuneXcite’s competitors?

    Araris, Biocon Biologics, Ability Pharma, Apellis Pharmaceuticals, and Alaunos Therapeutics are some of the 92 competitors of ImmuneXcite.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process